T
The startup develops immunomodulatory compounds for the treatment of autoimmune diseases, utilizing both subcutaneous and oral administration methods to shift the immune response from inflammatory to anti-inflammatory states. This approach enables healthcare professionals to effectively manage patient conditions with greater ease and precision.
Jerusalem, Israel
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops immunomodulatory compounds for the treatment of autoimmune diseases, utilizing both subcutaneous and oral administration methods to shift the immune response from inflammatory to anti-inflammatory states. This approach enables healthcare professionals to effectively manage patient conditions with greater ease and precision.